S 2613
Code | Size | Price |
---|
TAR-T34466-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34466-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
S 2613 is a luminogenic peptide substrate.
CAS:
84272-64-0
Molecular Weight:
799.931
Purity:
0.98
SMILES:
CC[C@H](C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CCC(=O)N1CCCCC1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc2c(c1)c(=O)[nH][nH]c2=O
References
Mazzei L, Garc?a IM, Cacciamani V, Benard?n ME, Manucha W. WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction. Biocell. 2010 Dec;34(3):121-32. PubMed PMID: 21443142.
Lindahl U, Kolset SO, B?gwald J, Osterud B, Seljelid R. Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J. 1982 Aug 15;206(2):231-7. PubMed PMID: 7150243; PubMed Central PMCID: PMC1158578.